News
EEST Darolutamide receives EU approval in third indication for patients with advanced prostate cancer European Commission ...
Abstract Purpose We examined whether the survival advantage of androgen-deprivation therapy with radiotherapy (ADT plus RT) relative to ADT alone for men with locally advanced prostate cancer reported ...
Prostate cancer ranks high among male mortality causes worldwide. In this article, Sandy Srinivas, MD, discusses androgen deprivation therapy as a treatment for advanced prostate cancer and ...
What is androgen deprivation therapy? Alicia Morgans, M.D., MPH: Androgen deprivation therapy, sometimes called ADT or hormonal therapy, is a way of treating prostate cancer that is used pretty ...
Drs Sandhya Srinivas and Rana R. McKay discuss bone health and survivorship, including risk factors and potential side effects with androgen deprivation therapy in patients with prostate cancer.
Men with oligometastatic castration-sensitive prostate cancer (CSPC) have improved outcomes when androgen deprivation therapy is added to metastasis-directed therapy (MDT).
Androgen deprivation therapy, death among patients with prostate cancer, COVID-19 ...
Which men benefit most from adding androgen deprivation therapy (ADT) to salvage radiation therapy (SRT) after prostatectomy has not clearly been defined; therefore, we evaluated the impact of ADT ...
Research helps explain why androgen-deprivation therapy doesn't work for many prostate cancers Study offers new insights on how to prevent or reverse therapeutic resistance Date: January 5, 2017 ...
PurposeTo test the association of androgen deprivation therapy (ADT) in the treatment of prostate cancer with subsequent Alzheimer’s disease risk.MethodsWe used a previously validated and implemented ...
Androgen deprivation therapy is commonly used to treat prostate cancer, often on an open-ended basis for therapy of advanced prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results